SCIENTIFIC BACKGROUND

B3GALNT2, B4GAT1, CHKB, COL6A1, COL6A2, COL6A3, CRPPA, DAG1, FHL1, FKRP, FKTN, GMPPB, ITGA7, LAMA2, LARGE1, POMGNT1, POMGNT2, POMK, POMT1, POMT2, RXYLT1, SELENON

Category:

Scientific Background

Muscular dystrophies cause progressive muscle weakness and degeneration. The underlying defects involve genes required for normal muscle function and the clinical manifestations are partially overlapping. Immunohistochemical or immunofluorescence staining can be used for the differentiation of some subtypes, such as dysferlinopathy, dystrophinopathy or sarcoglycanopathies. Many other defective proteins involved in the disease are not readily identifiable. The most frequently occurring muscular dystrophies are Duchenne muscular dystrophy, myotonic dystrophies, and fazioscapulohumeral muscular dystrophy. Less frequently occuring muscular dystrophies are limb-girdle, Emery-Dreifuss and the congenital muscular dystrophies. Pathogenic variants in many genes lead to this group of diseases and their differentiation often poses a great challenge.

 

Congenital muscular dystrophies (CMD) are rare, clinically and genetically heterogeneous with different, sometimes severe accompanying symptoms, such as malformations of the central nervous system or the eyes. The disease course is highly variable. Their prevalence is still largely unknown, although the frequency of certain subtypes varies within different population groups. Various classification strategies have been proposed, such as the classification of types into the following main categories:

 

  • Collagenopathies: autosomal recessive and autosomal dominant (also known as collagen VI associated myopathy), including Ullrich congenital muscular dystrophy and Bethlem myopathy
  • Merosinopathies: autosomal recessive (also known as merosine-deficient congenital muscular dystrophy)
  • Dystroglycanopathies: autosomal recessive (alpha-dystroglycan-associated muscular dystrophies) including Fukuyama congenital muscular dystrophy, muscle eye brain disease, Walker-Warburg syndrome, primary alpha-dystroglycanopathy and muscular dystrophy-dystroglycanopathy types 10, 11 and 14
  • Unclassified congenital muscular dystrophies: rigid-spine syndrome (SEPN1 and FHL1), multiminicore disease, limb-girdle muscular dystrophy (LMNA)

 

Muscular dystrophy, collagen-associated and others

Genes: CHKB, COL6A1, COL6A2, COL6A3, FHL1, ITGA7, SELENON

 

Muscular dystrophies, congenital

Genes: CHKB, COL6A1, COL6A2, COL6A3, CRPPA, DNM2, FHL1, FKRP, FKTN, ITGA7, LAMA2, LARGE1, LMNA, POMGNT1, POMGNT2, POMT1, POMT2, SELENON, TCAP

 

Muscular dystrophy, dystroglycanopathy type A (with brain and eye anomalies)

Genes: B3GALNT2, B4GAT1, CRPPA, DAG1, FKRP, FKTN, GMPPB, LARGE1, POMGNT1, POMGNT2, POMK, POMT1, POMT2, RXYLT1

 

Muscular dystrophy, dystroglycanopathy type A & B

Genes: B3GALNT2, B4GAT1, CRPPA, DAG1, FKRP, FKTN, GMPPB, LARGE1, POMGNT1, POMGNT2, POMK, POMT1, POMT2, RXYLT1

 

Muscular dystrophy, dystroglycanopathy type B (congenital, with mental retardation) & C

Genes: CRPPA, DAG1, FKRP, FKTN, GMPPB, LARGE1, POMGNT1, POMK, POMT1, POMT2

 

References

Falsaperla et al. 2016, Ital J of Ped 42:78 / Kang et al. 2015, Neurol 84:1369 / Dai et al. 2015, Neuromusc Dis 25:617 / Chae et al. 2015, J Med Genet 52:208 / Sparks et al. 2012, Genereviews

GENES

B3GALNT2, B4GAT1, CHKB, COL6A1, COL6A2, COL6A3, CRPPA, DAG1, FHL1, FKRP, FKTN, GMPPB, ITGA7, LAMA2, LARGE1, POMGNT1, POMGNT2, POMK, POMT1, POMT2, RXYLT1, SELENON
How to order

LATEST ARTICLES

Every year on April 25th, DNA Day celebrates the discovery of DNA’s double helix and the advances we’ve made in understanding genetics. D...

Read more

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f...

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced ...

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more